Rocket Pharmaceuticals' GAAP loss for 2021 was $169.069 million, up 21% from $139.7 million the previous year.
Rocket Pharmaceuticals' GAAP loss for 2021 was $169.069 million, up 21% from $139.7 million the previous year.
Rocket Pharmaceuticals reported for 2021
Rocket Pharmaceuticals' GAAP loss for 2021 was $169.069 million, up 21% from $139.7 million the previous year. Source: 
ir.rocketpharma.com
ir.rocketpharma.com
English (US) 